Unusual Discordant Responses in Two Multiple Myeloma Patients during Bortezomib Treatment

Publisher： Karger

E-ISSN： 2296-5262|31|1-2|45-47

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.1-2, 2008-01, pp. : 45-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effects of bortezomib on bone disease in patients with multiple myeloma

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 618-623

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-Angiogenic Effect of Bortezomib in Patients with Multiple Myeloma

By  

Acta Haematologica, Vol. 114, Iss. 3, 2005-10 ,pp. : 170-173

Karger

Access to resources Recommend Favorite

Effects of Age on Responses to Treatment and Survival of Patients with Multiple Myeloma

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 31, Iss. 5, 1983-05 ,pp. : 272-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe Epidermal Necrolysis after Bortezomib Treatment for Multiple Myeloma

By  

Acta Haematologica, Vol. 118, Iss. 2, 2007-05 ,pp. : 65-67

Karger

Access to resources Recommend Favorite

Treatment of Multiple Myeloma: Thalidomide-, Bortezomib-, and Lenalidomide-Induced Peripheral Neuropathy

By  

Oncology Research and Treatment, Vol. 37, Iss. 9, 2014-08 ,pp. : 506-513

Karger

Access to resources Recommend Favorite